Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. (Record no. 27475752)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02298 a2200673 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517170901.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201710s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1474-4457 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S1473-3099(17)30496-6 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Forns, Xavier |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20171002 |
245 00 - TITLE STATEMENT | |
Title | Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Lancet. Infectious diseases |
Date of publication, distribution, etc. | 10 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1062-1068 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aminoisobutyric Acids |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiviral Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzimidazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclopropanes |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hepacivirus |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hepatitis C |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lactams, Macrocyclic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leucine |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Cirrhosis |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proline |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrrolidines |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinoxalines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lee, Samuel S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Valdes, Joaquin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lens, Sabela |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ghalib, Reem |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aguilar, Humberto |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Felizarta, Franco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hassanein, Tarek |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hinrichsen, Holger |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rincon, Diego |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Morillas, Rosa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zeuzem, Stefan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Horsmans, Yves |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nelson, David R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yu, Yao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krishnan, Preethi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lin, Chih-Wei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kort, Jens J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mensa, Federico J |
773 0# - HOST ITEM ENTRY | |
Title | The Lancet. Infectious diseases |
Related parts | vol. 17 |
-- | no. 10 |
-- | p. 1062-1068 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1473-3099(17)30496-6">https://doi.org/10.1016/S1473-3099(17)30496-6</a> |
Public note | Available from publisher's website |
No items available.